Reply to "COVID vaccine-induced lichen planus on areas previously affected by vitiligo".

Bularca, E; Monte-Serrano, J; Villagrasa-Boli, P; Lapeña-Casado, A; de-la-Fuente, S

Bularca, E; Monte-Serrano, J; Villagrasa-Boli, P; Lapeña-Casado, A; de-la-Fuente, S.

Bularca E; Department of Dermatology, Lozano Blesa University Clinical Hospital of Zaragoza, Zaragoza, Spain.
Monte-Serrano J; Department of Dermatology, Lozano Blesa University Clinical Hospital of Zaragoza, Zaragoza, Spain.
Villagrasa-Boli P; Department of Dermatology, Lozano Blesa University Clinical Hospital of Zaragoza, Zaragoza, Spain.
Lapeña-Casado A; Department of Dermatology, Lozano Blesa University Clinical Hospital of Zaragoza, Zaragoza, Spain.
de-la-Fuente S; Department of Dermatology, Lozano Blesa University Clinical Hospital of Zaragoza, Zaragoza, Spain.

J Eur Acad Dermatol Venereol ; 36(6): e423-e425, 2022 06.

Article in English | MEDLINE | ID: covidwho-1685354

Subject(s)

COVID-19; Hypopigmentation; Lichen Planus; Vaccines; Vitiligo; COVID-19 Vaccines/adverse effects; Humans; Lichen Planus/chemically induced; Vitiligo/chemically induced

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vitiligo / Vaccines / Hypopigmentation / COVID-19 / Lichen Planus Topics: Vaccines Limits: Humans Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2022 Document Type: Article Affiliation country: Jdv.18001

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google